Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01054144
What this trial is testing

Study of Single Agent Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT07217184
What this trial is testing

Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Isatuximab in Participants With RRMM

Who this might be right for
Multiple Myeloma
GlaxoSmithKline 30
Not applicableLooking for participantsNCT07184307
What this trial is testing

Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial

Who this might be right for
Overactive Bladder SyndromeUrinary Urge IncontinenceDetrusor Overactivity
Benha University 48
Testing effectiveness (Phase 2)Study completedNCT02654132
What this trial is testing

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 117
Early research (Phase 1)Study completedNCT01830816
What this trial is testing

Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment

Who this might be right for
Multiple MyelomaAdvanced Solid Tumors
Millennium Pharmaceuticals, Inc. 41
Not applicableEnded earlyNCT05820932
What this trial is testing

Predicting Cognitive Decline From Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
University of California, San Francisco 32
Post-approval studies (Phase 4)Not Yet RecruitingNCT07474961
What this trial is testing

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

Who this might be right for
Waldenstrom MacroglobulinaemiaMultiple Myeloma
Anne Louise Tølbøll Sørensen 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05581875
What this trial is testing

Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Pomalidomide and Dexamethasone in Patients With Relapsed/ Refractory Multiple Myeloma Previously Treated With One Line Therapy Who Are Lenalidomide Refractory

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseNeoplasms+6 more
Hellenic Society of Hematology 48
Not applicableUnknownNCT03890172
What this trial is testing

Efficacy of Platelets Rich Plasma as a Therapeutic Tool in Diabetic Foot Ulcers

Who this might be right for
Diabetic Foot Ulcer
Assiut University 60
Not applicableStudy completedNCT06852131
What this trial is testing

Carpal Tunnel Syndrome Treatment: Surgery Vs. Injections

Who this might be right for
Carpal Tunnel Syndrome (CTS)
Ankara University 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03376672
What this trial is testing

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

Who this might be right for
Multiple Myeloma
Raija Silvennoinen 120
Large-scale testing (Phase 3)Study completedNCT04535063
What this trial is testing

Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia

Who this might be right for
Covid19 Pneumonia
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno 200
Large-scale testing (Phase 3)Study completedNCT02726581
What this trial is testing

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 170
Testing effectiveness (Phase 2)Study completedNCT00689000
What this trial is testing

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeMultiple Myeloma
Chroma Therapeutics 57
Very early researchNot Yet RecruitingNCT07586709
What this trial is testing

In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms

Who this might be right for
Plasma Cell Neoplasms
Liping Dou 18
Testing effectiveness (Phase 2)WithdrawnNCT02118311
What this trial is testing

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota
Large-scale testing (Phase 3)Study completedNCT00477971
What this trial is testing

Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 89
Not applicableNo Longer AvailableNCT02666209
What this trial is testing

Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma
Dana-Farber Cancer Institute
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00322387
What this trial is testing

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

Who this might be right for
Lymphoma, Non-HodgkinMultiple Myeloma
Genzyme, a Sanofi Company 40
Next Page